Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2005 3
2006 2
2008 1
2009 4
2010 1
2011 1
2012 1
2013 5
2014 2
2015 3
2016 3
2017 2
2018 4
2019 3
2020 4
2021 6
2022 4
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
High SLC20A1 Expression Indicates Poor Prognosis in Prostate Cancer.
Okamoto T, Onaga C, Matsuoka I, Ozaki A, Matsuda C, Kasai T, Xiong Y, Harada Y, Sato T, Nakano Y, Mano Y, Miyazaki S, Ishiguro H, Sato K, Tamori S, Sasaki K, Ohno S, Akimoto K. Okamoto T, et al. Among authors: akimoto k. Cancer Diagn Progn. 2023 Jul 3;3(4):439-448. doi: 10.21873/cdp.10237. eCollection 2023 Jul-Aug. Cancer Diagn Progn. 2023. PMID: 37405223 Free PMC article.
GLO 1 and PKCλ Regulate ALDH1-positive Breast Cancer Stem Cell Survival.
Motomura H, Tamori S, Yatani MA, Namiki A, Onaga C, Ozaki A, Takasawa R, Mano Y, Sato T, Hara Y, Sato K, Xiong Y, Harada Y, Hanawa T, Tanuma SI, Sasaki K, Ohno S, Akimoto K. Motomura H, et al. Among authors: akimoto k. Anticancer Res. 2021 Dec;41(12):5959-5971. doi: 10.21873/anticanres.15415. Anticancer Res. 2021. PMID: 34848450
High SLC20A1 Expression Is Associated With Poor Prognosis for Radiotherapy of Estrogen Receptor-positive Breast Cancer.
Onaga C, Tamori S, Matsuoka I, Ozaki A, Motomura H, Nagashima Y, Sato T, Sato K, Tahata K, Xiong Y, Nakano Y, Mano Y, Miyazaki S, Sasaki K, Ohno S, Akimoto K. Onaga C, et al. Among authors: akimoto k. Cancer Diagn Progn. 2022 Jul 3;2(4):429-442. doi: 10.21873/cdp.10126. eCollection 2022 Jul-Aug. Cancer Diagn Progn. 2022. PMID: 35813014 Free PMC article.
High Expression of p62 and ALDH1A3 Is Associated With Poor Prognosis in Luminal B Breast Cancer.
Ozaki A, Motomura H, Tamori S, Onaga C, Nagashima Y, Kotori M, Matsuda C, Matsuda A, Mochizuki N, Sato T, Hara Y, Sato K, Miyagi Y, Nagashima Y, Hanawa T, Harada Y, Xiong Y, Sasaki K, Ohno S, Akimoto K. Ozaki A, et al. Among authors: akimoto k. Anticancer Res. 2022 Jul;42(7):3299-3312. doi: 10.21873/anticanres.15818. Anticancer Res. 2022. PMID: 35790283
53 results